Immune responses are also correlated with tumor aggressiveness even in the absence of immunotherapies, as numbers of CD8+ T cells are recently described as predictive of survival in muscle-invasive and advanced urothelial carcinoma [28,29]. Here, CD8A is linked to neoplasm.